Adagene (ADAG) Receivables - Net (2019 - 2021)

Adagene's (ADAG) quarterly Receivables - Net came in at $3.0 million in Q4 2021, up 384.51% on a QoQ basis from $619185.0 in Q2 2021.

Adagene (ADAG) Receivables - Net (2019 - 2021) Analysis & Trends

Adagene (ADAG) has 2 years of Receivables - Net data on file, last reported at $3.0 million in Q4 2021.

On a quarterly basis, Receivables - Net changed N/A year-over-year to $3.0 million in Q4 2021; TTM through Dec 2021 was $3.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $3.0 million, changed N/A from the prior year.
Receivables - Net for Q4 2021 stood at $3.0 million, up from $619185.0 in the prior quarter.
Over the last five years, Receivables - Net for ADAG reached as high as $3.0 million in Q4 2021 and fell as low as $480000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Adagene	198.85 Mn	198.85 Mn	-

Download Data